We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$291M
AUM Growth
+$23.1M
Cap. Flow
+$269M
Cap. Flow %
92.57%
Top 10 Hldgs %
28.45%
Holding
666
New
45
Increased
120
Reduced
128
Closed
66

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$247M
2
BZUN
Baozun
BZUN
+$16.2M
3
SLQD icon
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
+$3.76M
4
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$2.33M
5
VRNS icon
Varonis Systems
VRNS
+$2.06M

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$3.88M
2
XNET
Xunlei
XNET
+$3.74M
3
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$1.27M
4
P
Everpure Inc
P
+$1.11M
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$844K

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.14%
2 Technology 17.01%
3 Consumer Discretionary 13.56%
4 Communication Services 12.87%
5 Healthcare 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLXN
551
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4K ﹤0.01%
200
– –
LEXEA
552
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$4K ﹤0.01%
95
– –
FL
553
DELISTED
Foot Locker
FL
$3K ﹤0.01%
68
– –
PJT icon
554
PJT Partners
PJT
$4.67B
$3K ﹤0.01%
50
– –
TOVX icon
555
Theriva Biologics
TOVX
$11.2M
$3K ﹤0.01%
1
– –
UNM icon
556
Unum
UNM
$14.7B
$3K ﹤0.01%
54
– –
NMTR
557
DELISTED
9 Meters Biopharma
NMTR
$3K ﹤0.01%
+5
New +$973
SNMX
558
DELISTED
Senomyx, Inc.
SNMX
$3K ﹤0.01%
3,000
– –
CBB
559
DELISTED
Cincinnati Bell Inc.
CBB
$3K ﹤0.01%
217
– –
CELG
560
PUT
DELISTED
Celgene Corp
CELG
$3K ﹤0.01%
+500
New +$48K
IMDZ
561
DELISTED
Immune Design Corp.
IMDZ
$3K ﹤0.01%
+1,000
New +$3.54K
ADI icon
562
Analog Devices
ADI
$175B
$2K ﹤0.01%
20
– –
BMY icon
563
PUT
Bristol-Myers Squibb
BMY
$136B
$2K ﹤0.01%
+500
New +$32.2K
FSM icon
564
Fortuna Silver Mines
FSM
$3.63B
$2K ﹤0.01%
350
– –
GYRE icon
565
Gyre Therapeutics
GYRE
$699M
$2K ﹤0.01%
9
– –
INVH icon
566
Invitation Homes
INVH
$17.4B
$2K ﹤0.01%
102
– –
JAZZ icon
567
Jazz Pharmaceuticals
JAZZ
$15.9B
$2K ﹤0.01%
16
– –
KR icon
568
Kroger
KR
$35.4B
$2K ﹤0.01%
94
– –
LITE icon
569
Lumentum
LITE
$80.3B
$2K ﹤0.01%
25
– –
SNAP icon
570
Snap
SNAP
$9.18B
$2K ﹤0.01%
100
– –
SWIR
571
DELISTED
Sierra Wireless
SWIR
$2K ﹤0.01%
100
– –
EVHC
572
DELISTED
Envision Healthcare Holdings Inc
EVHC
$2K ﹤0.01%
55
– –
ABBV icon
573
CALL
AbbVie
ABBV
$451B
$1K ﹤0.01%
+600
New +$65.9K
AMD icon
574
Advanced Micro Devices
AMD
$760B
$1K ﹤0.01%
100
-43,500
-100% -$516K
BLK icon
575
Blackrock
BLK
$180B
$1K ﹤0.01%
1
– –
21 22
23
24 25

Similar funds

PFA
Professional Financial Advisors North Platte, Nebraska $578M AUM 19.5% 1-Year Est. Return
AFGAS
Allegiance Financial Group Advisory Services Vienna, Virginia $578M AUM 24.83% 1-Year Est. Return
RWM
Rezny Wealth Management Fort Myers, Florida $579M AUM 34.89% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CTAF
Call To Action Foundation Salt Lake City, Utah $579M AUM 20.91% 1-Year Est. Return
HIM
HughesLittle Investment Management Vancouver $577M AUM 21.98% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Intellectus Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Intellectus Partners held 666 positions worth $291M, up 8.6% from $268M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Intellectus Partners deployed $269M of net new capital in Q1 2018, opening 45 new positions and adding to 120 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 800 shares worth $102K.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Xunlei, an estimated $3.74M trimmed.

  • Intellectus Partners's largest Q1 2018 buy was Berkshire Hathaway Class A: 800 shares worth $102K.
  • Intellectus Partners added most to Baidu in Q1 2018, an estimated $1.31M increase.
  • Intellectus Partners's biggest Q1 2018 reduction was Xunlei, cutting an estimated $3.74M.
  • Intellectus Partners fully exited ASML in Q1 2018, selling an estimated $3.88M.
  • Intellectus Partners's ten largest holdings make up 28% of its $291M portfolio in Q1 2018.
  • Intellectus Partners opened 45 new positions and closed 66 in Q1 2018.
  • Intellectus Partners's portfolio value rose 8.6% quarter-over-quarter to $291M.

Based on Intellectus Partners's 13F filing for Q1 2018, filed 15 May 2018.